nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Corrigendum to “A novel platinum(IV) prodrug, gramine-Pt(IV) enhances chemoimmunotherapy by activating cGAS-STING and modulating TGF-β-MHC-I axis” [Drug Resist. Updates 81 (2025) 101252]
|
Ding, Bowen |
|
|
82 |
C |
p. |
artikel |
2 |
Corrigendum to “NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-I” [Drug Resist. Updates 73 (2024) 101040]
|
Zhang, Zhiheng |
|
|
82 |
C |
p. |
artikel |
3 |
Editorial Board
|
|
|
|
82 |
C |
p. |
artikel |
4 |
Exosome-derived lnc-FAM72D-3 promotes lenvatinib resistance by remodeling hepatocellular carcinoma cytoskeleton via MBNL1/FAK axis
|
Cao, Mingbo |
|
|
82 |
C |
p. |
artikel |
5 |
Global, regional, and national disease burden of multidrug-resistant tuberculosis without extensive drug resistance, 1990–2021: Findings from the Global Burden of Disease Study 2021
|
Wang, Xinyue |
|
|
82 |
C |
p. |
artikel |
6 |
Hypoxia-induced upregulation of HIF1A-AS3 promotes MSC transition to cancer-associated fibroblasts and confers drug resistance in gastric cancer
|
Xu, Jiajin |
|
|
82 |
C |
p. |
artikel |
7 |
Metabolic reprogramming of tumor-associated macrophages via adenosine-A2AR signaling drives cross-resistance in non-small cell lung cancer
|
Ding, Wen |
|
|
82 |
C |
p. |
artikel |
8 |
Molecular mechanisms of acquired resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
|
Du, Zhenfang |
|
|
82 |
C |
p. |
artikel |
9 |
Spatial discovery of pyrotinib overcoming HER2-positive breast cancer resistance by breaking fibroblast-induced immune barriers
|
Yang, Chenghui |
|
|
82 |
C |
p. |
artikel |
10 |
The multifaceted contributions of cancer-associated fibroblasts to drug resistance in primary and metastatic tumors
|
Zhang, Xinhao |
|
|
82 |
C |
p. |
artikel |
11 |
The shadow of cancer therapeutic resistance: Unveiling the role of S-palmitoylation
|
Yang, Xue |
|
|
82 |
C |
p. |
artikel |
12 |
TRIM24 promotes T-cell lymphoma development and glucocorticoid resistance via FUS-mediated phase separation of the glucocorticoid receptor
|
Wang, Chen |
|
|
82 |
C |
p. |
artikel |
13 |
ZNF207-driven PRDX1 lactylation and NRF2 activation in regorafenib resistance and ferroptosis evasion
|
Yang, Tianfeng |
|
|
82 |
C |
p. |
artikel |